PD37-09 The First Report Of Disease-Free Survival Analyses From The Niagara Trial Of Perioperative Durvalumab Plus Neoadjuvant Chemotherapy In Muscle-Invasive Bladder Cancer: Erratum [0.03%]
肌层浸润性膀胱癌新辅助化疗联合围手术期度伐单抗尼亚加拉试验无病生存分析的首次报道：勘误表
Joshua J Meeks,Michiel S van der Heijden,Thomas Powles et al.
Joshua J Meeks et al.
Editorial Comment [0.03%]
编者按词典
Ahmed A Hussein
Ahmed A Hussein
Editorial Comment [0.03%]
编者按
Wesley H Chou,Sudhir Isharwal
Wesley H Chou
Diagnostic Accuracy of the Oncuria-Detect Multiplex Immunoassay in Detecting Upper Tract Urothelial Carcinoma [0.03%]
Oncuria-Detect 多联免疫测定法检测上尿路尿路上皮癌诊断准确性分析
Kazutoshi Fujita,Makito Miyake,Mamoru Hashimoto et al.
Kazutoshi Fujita et al.
Purpose: Urine-based assays currently have a limited role in the management of patients with upper tract urothelial carcinoma (UTUC), due to insufficient accuracy. This study evaluated a multiplex urine assay designed to ...
The Artificial Urinary Sphincter Clinical Outcomes Trial: Primary Results [0.03%]
人造尿道括约肌临床疗效试验：初步结果
Melissa R Kaufman,Hadley M Wood,Ryan Terlecki et al.
Melissa R Kaufman et al.
Purpose: The artificial urinary sphincter endures as the standard of care treatment for mild to severe male stress urinary incontinence. Prior studies report outcomes from predominantly single-center retrospective series....
The risk of clinically significant prostate cancer on subsequent biopsies in men with HGPIN/ASAP on an MRI-informed index biopsy [0.03%]
初始MRI引导系统针活检诊断HGPIN和ASAP患者后续活检发现临床显著前列腺癌的风险较高
Ana M Moser,Alissa Elanjian,Ava Zamani et al.
Ana M Moser et al.
Multicenter Analysis of Long-Term Outcomes of Artificial Urinary Sphincter Surgery Following Urethroplasty [0.03%]
尿道重建术后人工尿道括约肌手术长期疗效的多中心分析
Meghan F Davis,Dmitriy Nikolavsky,Andre G Cavalcanti et al.
Meghan F Davis et al.
Purpose: The artificial urinary sphincter (AUS) is the gold standard for male stress urinary incontinence (SUI). There is limited and conflicting evidence examining outcomes in AUS insertion after urethroplasty particular...
Benign Prostatic Hyperplasia [0.03%]
良性前列腺增生
Steven A Kaplan
Steven A Kaplan
Detection of Clinically Significant Prostate Cancer Using Micro-Ultrasound Versus MRI/Ultrasound Fusion Biopsy: A Propensity-Weighted Comparative Study [0.03%]
微超声检测临床显著性前列腺癌与MRI/超声融合活检的比较研究：倾向加权比较研究
Rafael Castilho Borges,Rafael Rocha Tourinho-Barbosa,Nuno Dias et al.
Rafael Castilho Borges et al.
Purpose: To compare the detection rates of clinically significant prostate cancer (csPCa) between cognitively targeted micro-ultrasound-guided biopsy (MB) and MRI/ultrasound fusion-guided biopsy (PFB) in men with MRI-visi...
Reply by Authors [0.03%]
作者回函
Matilde R Chacón
Matilde R Chacón